Jordan Lake, M.D., M.Sc., a new faculty member recruited to the Division of Infectious Diseases, Department of Internal Medicine, has been recognized as a Rising STAR by The University of Texas System.
Lake is joining McGovern Medical School as an associate professor, effective Sept 1. As part of her recruitment she is being awarded a Rising STARS Award from the UT System.
The UT System Board of Regents created the Faculty Science and Technology Acquisition and Retention (STARs) Program in 2004 to help UT institutions attract and retain outstanding faculty. Awards, which can be used to purchase equipment and renovate facilities, require institutional support and are available to support the recruitment of tenure-track faculty members at any rank.
Lake comes to McGovern Medical School from the University of California, Los Angeles, where she is a clinician researcher focused on understanding the link between chronic inflammation and immune activation and the potentially devastating end-organ damage that occurs in individuals with HIV infection. She also has a targeted interest in optimizing HIV care in underserved communities.
“The Division of Infectious Diseases is very proud to now have both a Rising STAR, Dr. Lake, and a STAR, Dr. Cesar Arias, among our faculty,” said Barbara Murray, M.D., J. Ralph Meadows Professor and director of the Division of Infectious Diseases. “Dr. Lake’s unique research expertise fills a major void in our current research portfolio and helps to expand our HIV clinical research program in this critically important area.”
Lake completed her medical degree and internal medicine residency at Baylor College of Medicine. She completed both a fellowship in infectious diseases and a master’s of science degree in clinical research at UCLA. She is the recipient of numerous competitive grants and awards, including a NIMH-funded T32 training program for Post-doctoral Training in Global HIV Prevention Research, a NIA-funded Claude D. Pepper Older Americans Independence Center Career Development Award, an NIAID K23 award for Inflammation, Fibrosis and End-Organ Disease in HIV-Infected Adults, and a Gilead Sciences Research Scholars Program in HIV Award.
“We are grateful to UT System for their support of this STARs Award. Recruitment of Dr. Lake further strengthens our infectious diseases program,” Dean Barbara J. Stoll said. “Dr. Lake’s clinical outreach experience and her integrated approach to team science will be of great value to the communities we serve and to the medical school.”
STARs Award funding will purchase a Fibroscan machine for Lake to conduct studies to treat and prevent non-alcoholic fatty liver disease and adipose tissue fibrosis as well as provide for the expansion of the current HIV clinical program into South Texas.
“Dr. Lake’s multi-disciplinary approach to HIV will not only benefit current and future patients but help bridge the work of our UTHealth scientists,” said Dr. George Stancel, executive vice president for academic and research affairs and holder of the Roger J. Bulger, M.D. Distinguished Professorship.